Farringdon Capital’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$209K Sell
948
-333
-26% -$92.1K 0.1% 162
2026
Q1
$378K Sell
1,281
-8,077
-86% -$2.4M 0.08% 260
2025
Q4
$2.56M Buy
9,358
+5,041
+117% +$1.37M 0.63% 35
2025
Q3
$1.17M Buy
4,317
+1,763
+69% +$480K 0.3% 90
2025
Q2
$704K Buy
+2,554
New +$695K 0.24% 126

Other funds holding CME

Farringdon Capital's CME Position: Q2 2026 in Review

Farringdon Capital reduced its CME Group (CME) stake by 26% in Q2 2026, selling an estimated $92.1K and leaving 948 shares worth $209K. The position accounts for 0.1% of the portfolio, ranked #162.

Farringdon Capital first reported a position in CME in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.56M in Q4 2025. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Farringdon Capital held 948 shares of CME Group worth $209K as of Q2 2026.
  • Farringdon Capital sold 333 CME Group shares in Q2 2026, an estimated $92.1K.
  • CME Group made up 0.1% of Farringdon Capital's portfolio in Q2 2026, its #162 holding.
  • Farringdon Capital first reported a position in CME Group in Q2 2025 and has held it in 5 quarters since.
  • Farringdon Capital's CME Group position peaked at $2.56M in Q4 2025.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Farringdon Capital's 13F filing for Q2 2026, filed 12 Aug 2026.